EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
The Translational Gap Is Killing Your Best Molecules
In todays rapidly evolving drug development landscape the translational gap has emerged as a critical challenge that is fundamentally reshaping how organizations approach research and development Its not just a scientific problem its a strategic imperative
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently
Thymidylate synthase TS is a key enzyme in thymidylate biosynthesis and an established target of chemotherapeutics such as fluorodeoxyuridine FdUR and raltitrexed RTX Inhibition of TS disrupts
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Bridging the Gap: Advancing In Vitro to In Vivo Gene Therapies
Kate Williamson
Bridging the Gap: Advancing In Vitro to In Vivo Gene Therapies explores the challenges and innovations in transitioning gene therapies from laboratory success to clinical application. Highlighting adv...
-
2
-
3
Innovations in Antibody-Drug Conjugates: A Deep Dive into Pharma's Future
Kate Williamson
Antibody-Drug Conjugates (ADCs) for cancer therapy, are truly a hybrid of both monoclonal antibodies as well as cytotoxic drugs. In this article, we shall focus on the future developments of the ADC t...
-
4
How to Successfully Enter the American Pharma Market?
Kate Williamson
Entering the North American pharmaceutical market demands a comprehensive strategy. Understanding FDA regulations, conducting thorough market analysis, building strategic partnerships, adapting to hea...
-
5
Revolutionizing Drug Design for a Brighter Future: Harnessing the Power of Artificial Intelligence and Machine Learning
Vidya Niranjan
In this editorial, we explore the remarkable potential of artificial intelligence (AI) and machine learning (ML) in revolutionizing the field of drug design. Traditional drug discovery pipelines have...
press releasesRead more...
Cerenome Launches as an Integrated CNS Oncology Company
Plus Therapeutics Inc Nasdaq PSTV the Company today announces that its corporate rebrand to Cerenome will be completed as scheduled Effective August the Companys name will become Cerenome
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
Glucotrack NASDAQ GCTK today announced the continued expansion of the ai Futures Lab operated through its wholly owned subsidiary Lkahi Therapeutics Inc During its first year the ai Futures Lab identified
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure
Ratio Therapeutics Inc Ratio a clinicalstage pharmaceutical company developing bestinclass radiopharmaceuticals for cancer treatment today announced the closing of a million Series C financing
EVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States
EVERSANA a leading provider of global commercialization services to the life sciences industry today announced it has been selected by Tokyobased biotechnology company Innovacell Inc as its exclusive
Events Read more...
03 - 04
Aug 2026Clinical Pharmacology and Toxicology 2026
Dubai, UAE
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
LATEST NEWSRead more...
Rose Hill Life Sciences and Control Z Partner to Advance Psilocybin-Assisted Therapy for PTSD
Rose Hill Life Sciences has signed a Letter of Intent LOI with Control Z to develop a clinically structured psilocybinassisted therapy programme for posttraumatic stress disorder PTSD through Rose Hills Psychedelic Therapeutic Intervention PTI platform
FDA Approves Meitheal’s Garzulys Biosimilar Insulin for Diabetes Treatment
Meitheal Pharmaceuticals has announced that the US Food and Drug Administration FDA has approved Garzulys insulin aspartfsan injection a biosimilar to NovoLog insulin aspart for the treatment of diabetes mellitus
Capsa Healthcare Launches RoboPharma Automation Platform Powered by Axona
Capsa Healthcare has introduced RoboPharma powered by Axona an integrated automation and enterprise software platform designed to support centralised pharmacy operations including
Octapharma to Invest US$1.5 Billion in First US Manufacturing Facility in South Carolina
Octapharma has announced plans to invest US billion in a new manufacturing and production facility at the Palmetto Research Park in Rock Hill South Carolina The project marks the companys first manufacturing site in the United States and is expected to create approximately full
TScan Therapeutics Doses First Patient in Phase 3 Trial of TSC-101 for Blood Cancers
TScan Therapeutics has dosed the first patient in its pivotal Phase ALLOHA trial evaluating TSC for the treatment of residual disease following allogeneic haematopoietic cell transplantation
Xencor to Receive US$105 Million From Alexion to Settle Ultomiris US Royalty Dispute
Xencor has reached an agreement with Alexion Pharma International Operations to resolve a commercial dispute over US royalties related to Ultomiris ravulizumabcwvz Under the settlement Xencor will receive US
